Skip to Main Content

Advertisement

Skip Nav Destination

Combined Therapy of Mice Bearing a Lymphokine-activated Killer-resistant Tumor with Recombinant Interleukin 2 and an Antitumor Monoclonal Antibody Capable of Inducing Antibody-dependent Cellular Cytotoxicity1

Cancer Res (1988) 48 (5): 1173–1179.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal